Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Terrance Ocheltree"'
Autor:
Elizabeth I. O. Garner, Janet Wittes, Terrance Ocheltree, Irina Krause, Joseph Chiodo, Michael Tuley, Jessica Case
Publikováno v:
Advances in Therapy. 36:3381-3389
AG200-15, an investigational transdermal contraceptive delivery system or patch, is designed to be a low-dose, non-daily, combined hormonal contraceptive option for women. In this phase 1 study, the in vivo adhesion of the AG200-15 patch was compared
Autor:
Katharine J Bee, Sharon Chinthrajah, Terrance Ocheltree, Amy M. Scurlock, Hugh A. Sampson, Dianne E. Campbell, Aurélie Peillon, T. Green, David Fleischer
Publikováno v:
Allergy and asthma proceedings. 41(5)
Background: Epicutaneous immunotherapy (EPIT) for peanut allergy is a potential novel immunotherapy that utilizes the unique cutaneous immunologic properties to induce desensitization. A randomized, double-blind, placebo-controlled Phase 3 trial (PEP
Autor:
David Fleischer, Edwin H. Kim, Terrance Ocheltree, Jonathan M. Spergel, Romain Lambert, Dianne E. Campbell, Hugh A. Sampson, T. Green, Katharine J Bee
Publikováno v:
Allergy and asthma proceedings. 41(4)
Background: Epicutaneous immunotherapy is a potential novel immunotherapy that utilizes unique cutaneous immunologic properties. In a phase III, randomized, double-blind, placebo controlled clinical trial, an epicutaneous patch (DBV712) with 250 µg
Autor:
Angelica Dorantes, Vinod P. Shah, Richard Owen Mannion, Patrick K. Noonan, Colleen Ruegger, Glenn A. Van Buskirk, Bruce Thompson, Ryan MacKenzie, Satish Asotra, Matthew Howard, Theresa Henry, Satyam Upadrashta, Christopher Balducci, Tapash Ghosh, Richard P. Poska, Ramani R. Raghavan, Terrance Ocheltree, Eric Sanchez, Prabir K. Basu, Jason Kamm, Gerald C. DiDonato, Mario A. Gonzalez, Michael L. Putnam, Steven Laurenz, Umesh Pai, Russell Somma, Avinash G. Thombre, Robert Joseph Timko, W. Mark Eickhoff, Vijay Tammara, Sivakumar Vaithiyalingam, Zezhi Jesse Shao
Publikováno v:
AAPS PharmSciTech
In this whitepaper, the Manufacturing Technical Committee of the Product Quality Research Institute provides information on the common, best practices in use today in the development of high-quality chemistry, manufacturing and controls documentation
Autor:
Robert Justice, Shakun M. Malik, Richard Pazdur, Rajeshwari Sridhara, Alice Kacuba, Julie Bullock, Terrance Ocheltree, Ke Liu, Gene M. Williams, Milinda Vialpando, Anshu Marathe, Shenghui Tang, S. Leigh Verbois, W. David McGuinn, Xu Qiang, Sue Ching Lin, Christoffer W. Tornøe
Publikováno v:
Clinical Cancer Research. 16:4921-4927
Purpose: On September 24, 2009, the U.S. Food and Drug Administration granted accelerated approval for Folotyn (pralatrexate injection, Allos Therapeutics, Inc.) as a single agent for the treatment of patients with relapsed or refractory peripheral T
Autor:
Vinod P. Shah, Patrick K. Noonan, Bing Cai, Mario A. Gonzalez, Lawrence H. Block, Terrance Ocheltree, Thomas S. Spencer, Prabir K. Basu, Peter Schwarz, Gary W. Cleary, David Kanios, Margareth Marques, Lino Tavares, Rajendra Uppoor, Tapash Ghosh, Thean Yeoh, Glenn A. Van Buskirk, Daniel Arsulowicz, Katherine Lynn Ulman
Publikováno v:
AAPS PharmSciTech
In this whitepaper, the Manufacturing Technical Committee (MTC) of the Product Quality Research Institute has updated the 1997 Transdermal Drug Delivery Systems Scale-Up and Post Approval Change workshop report findings to add important new product d
Autor:
Christoffer Tornoe, Weishi Yuan, Michael Brave, Shwu-Luan Lee, Haleh Saber, Sarah Pope Miksinski, Terrance Ocheltree, Sue Ching Lin, Ann T. Farrell, Brian Booth, Richard Pazdur, Robert Justice, Jeanne Fourie, Kun He
Publikováno v:
Oncology. 78(3-4)
Purpose: On December 15, 2008, the US Food and Drug Administration approved plerixafor (Mozobil®; Genzyme Corp.), a new small-molecule inhibitor of the CXCR4 chemokine receptor, for use in combination with granulocyte colony-stimulating factor (G-CS